For most people, a diagnosis of G6PD deficiency comes with a lot of questions. What does it mean? Will it affect daily life? What happens if something goes wrong? One of the most important things to understand early on is the connection between G6PD deficiency and hemolytic anemia, specifically what it is, why it happens, and what to watch for.
The good news is that the majority of people with G6PD deficiency live completely normal, healthy lives. Most have no obvious clinical symptoms in the absence of triggers and are often unaware they carry the condition at all. But when a trigger is encountered, the body’s response can come on quickly and, in some cases, seriously. Understanding how G6PD deficiency and hemolytic anemia are connected gives families and individuals the knowledge they need to act fast when it matters most.
What Is G6PD Deficiency and Why Does It Lead to Hemolytic Anemia?
G6PD deficiency is an inherited genetic enzyme disorder, and it is actually the most common inherited enzyme deficiency in the world. It was first discovered in 1956 as the cause of hemolytic anemia that developed in some individuals after they were given the antimalarial drug primaquine. It was later recognized as the cause of a condition called Favism, which refers to the reaction some people have after eating fava beans. The common factor between primaquine and fava beans, it turned out, is their propensity to cause oxidative stress.
To understand why that matters, it helps to understand what G6PD actually does. Glucose-6-phosphate dehydrogenase is an enzyme found in every cell in the body. Its function is to produce a substance called NADPH, which is critical both for cells to make other compounds and to protect the body against oxidative stress. In red blood cells specifically, NADPH is the only available source of protection against oxidative damage. Since the primary job of a red blood cell is to carry oxygen from the lungs to the rest of the body, it is especially vulnerable when that protection is compromised.
When a person with G6PD deficiency is exposed to something that causes oxidative stress, and their red blood cells do not have enough of the protective NADPH that G6PD normally produces, those red blood cells become vulnerable. They start breaking down faster than the body can replace them. That breakdown is called hemolysis. When hemolysis outpaces production, the result is G6PD deficiency and hemolytic anemia, a condition in which there are not enough healthy red blood cells to carry adequate oxygen through the body.
What Triggers G6PD Deficiency and Hemolytic Anemia?
G6PD deficiency and hemolytic anemia do not happen on their own. They require a trigger, an external stimulus that causes the oxidative stress the body cannot adequately manage. According to the foundation’s own lifestyle guide and clinical resources, there are several well-established categories of triggers.
The first and perhaps most famous is food. Fava beans are the most well-documented dietary trigger, and their connection to G6PD deficiency has been recognized for centuries. Other legumes including soy, peanuts, peas, and fenugreek have also been noted as possible triggers, as has bitter melon, which contains the same compound found in fava beans. Artificial food dyes in processed foods are also on the list.
Medications are another significant category. The foundation’s lifestyle guide identifies a number of medications that are known to carry risk for people with G6PD deficiency, including antimalarial drugs like primaquine, chloroquine, and hydroxychloroquine, sulfa drugs and dapsone, certain urinary infection drugs including nitrofurantoin and nalidixic acid, aspirin and aspirin-containing products, and certain chemotherapy agents. It is essential for anyone with G6PD deficiency to inform every doctor, dentist, and pharmacist about their diagnosis before starting any new medication or treatment.
Perhaps the most commonly overlooked trigger is illness itself. Despite the focus that is often placed on food and medication triggers, there is reason to believe that infection is actually the most common precipitating factor for G6PD deficiency and hemolytic anemia. Both viral and bacterial infections have been implicated. The foundation’s own lifestyle guide states plainly that sickness such as a cold or influenza is known to start the onset of G6PD deficiency symptoms. Avoiding getting run down is not just good general health advice for someone with this condition. It is one of the most important protective measures available.
Environmental exposures also matter. Naphthalene, the chemical found in mothballs, is a known trigger. Henna dyes for hair and tattoos are on the list. Camphor and mentholated products are flagged as well, alongside certain household drain, oven, and bathroom cleaners that contain naphtylhydroxylamine.
Recognizing the Symptoms of a Hemolytic Episode
The connection between G6PD deficiency and hemolytic anemia becomes critically important when it comes to recognizing symptoms in time to act. An episode does not always announce itself dramatically. It often begins with feelings that might be dismissed as fatigue or a passing illness, which is exactly what makes awareness so essential.
In adults, the foundation identifies the following signs of a hemolytic episode:
- Yellowing of the skin and eyes, known as jaundice
- Darker than usual urine
- Fever and fatigue
- Rapid heart rate and shortness of breath
- Confusion, lightheadedness, or dizziness
- Back or abdominal pain
- Heart murmur
- Enlarged spleen or liver
- Blue or grey fingernail color, or pale skin
Acute hemolytic anemia is usually characterized by malaise, fatigue, or weakness and abdominal or back pain first. After a day or so, jaundice and dark urine appear and anemia develops. That progression is worth understanding clearly. The first signs can feel vague and non-specific. It is only as the episode develops that the more visible signs like yellowing skin and dark urine appear. By that point, the episode is already well underway, which is why taking the early signs seriously matters so much.
In newborns, the signs of G6PD deficiency and hemolytic anemia look somewhat different and can escalate even more quickly. The foundation identifies the following warning signs in infants:
- Yellowing of the skin and eyes, which is severe if it extends below the abdomen
- Darker than usual urine
- Fever, lethargy, extreme sleepiness, and loss of appetite
- Rapid heart rate and shortness of breath
- Arching back movements
- Seizures or convulsions
- Changes in normal muscle tone, either too loose or too rigid
- Enlarged spleen or liver
- High-pitched crying
Any of these signs in a newborn, especially in combination with visible jaundice, should be treated as urgent. The jaundice toxins associated with severe G6PD deficiency and hemolytic anemia in newborns can cause brain damage or death if not addressed promptly.
Not all cases of G6PD deficiency carry the same level of risk for hemolytic anemia. The World Health Organization classifies genetic variants of G6PD deficiency into four categories based on measured enzyme activity and associated clinical presentations.
Class A represents the most severe form, where enzyme activity is less than 20 percent of normal. This class is associated with Chronic Non-Spherocytic Hemolytic Anemia, a complicated and variable syndrome. People in this class may have ongoing anemia, an enlarged spleen, and gallstones, and triggers that cause acute episodes can make their baseline condition significantly worse.
Class B is characterized by enzyme activity that is less than 45 percent of normal and is associated with episodes of acute hemolytic anemia. This class includes all the common polymorphic variants of G6PD deficiency, all of which carry the risk of neonatal jaundice and acute hemolytic anemia when triggered by certain foods, infections, chemicals, or drugs.
Class C reflects enzyme activity greater than 60 percent of normal and is not associated with hemolysis.
Class U is a temporary classification for cases where the enzyme activity level is known but the clinical significance is uncertain, pending further research.
It is important to note, as the WHO does, that this classification system is for genetic variants and should not be used to classify individual patients. Understanding one’s specific variant and what it means is a conversation best had directly with a healthcare provider.
Chronic Non-Spherocytic Hemolytic Anemia
While most discussions of G6PD deficiency and hemolytic anemia focus on acute episodes triggered by specific exposures, it is worth understanding that in some cases, hemolysis can be ongoing rather than episodic. Chronic Non-Spherocytic Hemolytic Anemia is a form associated with the most severe G6PD deficiency variants and is characterized by a wide range of severity depending on the specific mutation involved. In many cases there is a history of neonatal jaundice, and individuals with this form may experience ongoing anemia as well as an enlarged spleen and gallstones throughout their lives. Triggers that would cause an acute episode in someone with a less severe variant can cause acute exacerbations in these individuals on top of their chronic baseline condition.
What to Do If You Suspect a Hemolytic Episode
If you or someone you love has G6PD deficiency and you notice any of the signs described above, especially following a known exposure to a trigger, the most important thing is to seek medical attention promptly rather than waiting to see if symptoms resolve. In adults, acute hemolytic anemia is usually not life-threatening in developed countries when treated appropriately and promptly. In newborns, the situation can escalate quickly and is far more urgent.
Before any medical appointment or procedure, inform the provider about the G6PD deficiency diagnosis and ask them to review any proposed medications against the known list of unsafe substances. This is one of the simplest and most effective steps anyone with G6PD deficiency can take to reduce the risk of a hemolytic episode triggered by medical treatment.
Living well with G6PD deficiency is absolutely possible. As the foundation’s registered dietitian writes in the lifestyle guide, living with G6PD deficiency is not a death sentence. Nutrition and wellness are ways to protect against the products and medications that include known triggers. Each G6PD deficient individual may react to only certain triggers, and within a family who are deficient may not react to the same triggers. Every G6PD deficient individual has limits and triggers that can be very unpredictable, which is exactly why staying informed and staying connected to vetted resources is so valuable.
Follow us on Facebook for ongoing educational content, awareness updates, and community support.
Awareness is the difference. Help us spread it!
Recent Comments